Cost-utility Analysis of Molnupiravir for High-Risk, Community-Based Adults with COVID-19: an Economic Evaluation of the PANORAMIC Trial.
BRITISH JOURNAL OF GENERAL PRACTICE(2024)
Key words
antiviral drugs,cost-benefit analysis,COVID-19,molnupiravir,quality- adjusted life years,SARS-CoV-2
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined